Prognostic stratification of patients with biliary tract cancer treated with chemoimmunotherapy: A retrospective multicenter real‐world study
A novel prognostic index for patients with locally advanced or metastatic biliary tract cancer treated with first‐line therapy with cisplatin, gemcitabine, and durvalumab is explored and validated.